A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival
For many years, clinicians and scientists attempt to develop methods to stimulate the immune system to target malignant cells. Recent data suggest that effective cancer vaccination requires combination immunotherapies to overcome tumor immune evasion. Through presentation of both MHC-I and II molecu...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
International journal of cancer
Year: 2019, Volume: 144, Issue: 4, Pages: 909-921 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.31795 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1002/ijc.31795 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31795 
|
| Author Notes: | Adi Sharbi‐Yunger, Mareike Grees, Gal Cafri, David Bassan, Stefan B. Eichmüller, Esther Tzehoval, Jochen Utikal, Viktor Umansky and Lea Eisenbach |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 158780638X | ||
| 003 | DE-627 | ||
| 005 | 20230816140310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190219s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ijc.31795 |2 doi | |
| 035 | |a (DE-627)158780638X | ||
| 035 | |a (DE-576)51780638X | ||
| 035 | |a (DE-599)BSZ51780638X | ||
| 035 | |a (OCoLC)1341038822 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sharbi Yunger, Adi |e VerfasserIn |0 (DE-588)1178484688 |0 (DE-627)1049407652 |0 (DE-576)517806142 |4 aut | |
| 245 | 1 | 2 | |a A universal anti-cancer vaccine |b Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival |c Adi Sharbi‐Yunger, Mareike Grees, Gal Cafri, David Bassan, Stefan B. Eichmüller, Esther Tzehoval, Jochen Utikal, Viktor Umansky and Lea Eisenbach |
| 264 | 1 | |c 2019 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online 14 Aug 2018 | ||
| 500 | |a Gesehen am 19.02.2019 | ||
| 520 | |a For many years, clinicians and scientists attempt to develop methods to stimulate the immune system to target malignant cells. Recent data suggest that effective cancer vaccination requires combination immunotherapies to overcome tumor immune evasion. Through presentation of both MHC-I and II molecules, DCs-based vaccine platforms are effective in generating detectable CD4 and CD8 T cell responses against tumor-associated antigens. Several platforms include DC transfection with mRNA of the desired tumor antigen. These DCs are then delivered to the host and elicit an immune response against the antigen of interest. We have recently established an mRNA genetic platform which induced specific CD8+ cytotoxic T cell response by DC vaccination against melanoma. In our study, an MHC-II mRNA DCs vaccine platform was developed to activate CD4+ T cells and to enhance the anti-tumor response. The invariant chain (Ii) was modified and the semi-peptide CLIP was replaced with an MHC-II binding peptide sequences of melanoma antigens. These chimeric MHC-II constructs are presented by DCs and induce proliferation of tumor specific CD4+ T cells. When administered in combination with the MHC-I platform into tumor bearing mice, these constructs were able to inhibit tumor growth, and improve mouse survival. Deciphering the immunological mechanism of action, we observed an efficient CTLs killing in addition to higher levels of Th1 and Th2 subsets in the groups immunized with a combination of the MHC-I and MHC-II constructs. These universal constructs can be applied in multiple combinations and offer an attractive opportunity to improve cancer treatment. | ||
| 650 | 4 | |a chimeric construct | |
| 650 | 4 | |a dendritic Cells | |
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a MHC Class II | |
| 650 | 4 | |a mRNA | |
| 650 | 4 | |a vaccine | |
| 700 | 1 | |a Grees, Mareike |d 1980- |e VerfasserIn |0 (DE-588)1138718815 |0 (DE-627)896262073 |0 (DE-576)492658471 |4 aut | |
| 700 | 1 | |a Eichmüller, Stefan B. |d 1960- |e VerfasserIn |0 (DE-588)1025289226 |0 (DE-627)721986951 |0 (DE-576)37016704X |4 aut | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 700 | 1 | |a Umansky, Viktor |d 1955- |e VerfasserIn |0 (DE-588)102885756X |0 (DE-627)731733207 |0 (DE-576)376300078 |4 aut | |
| 700 | 1 | |a Eisenbach, Lea |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 144(2019), 4, Seite 909-921 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a A universal anti-cancer vaccine Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival |
| 773 | 1 | 8 | |g volume:144 |g year:2019 |g number:4 |g pages:909-921 |g extent:13 |a A universal anti-cancer vaccine Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ijc.31795 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31795 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190219 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 60000 |d 61900 |d 140000 |e 60000PU102885756X |e 61900PU102885756X |e 140000PU102885756X |k 0/60000/ |k 1/60000/61900/ |k 0/140000/ |p 8 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 7 | ||
| 998 | |g 1025289226 |a Eichmüller, Stefan B. |m 1025289226:Eichmüller, Stefan B. |d 140000 |d 60000 |e 140000PE1025289226 |e 60000PE1025289226 |k 0/140000/ |k 0/60000/ |p 5 | ||
| 998 | |g 1138718815 |a Grees, Mareike |m 1138718815:Grees, Mareike |d 60000 |d 61900 |e 60000PG1138718815 |e 61900PG1138718815 |k 0/60000/ |k 1/60000/61900/ |p 2 | ||
| 999 | |a KXP-PPN158780638X |e 305621131X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"158780638X","physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Adi Sharbi‐Yunger, Mareike Grees, Gal Cafri, David Bassan, Stefan B. Eichmüller, Esther Tzehoval, Jochen Utikal, Viktor Umansky and Lea Eisenbach"]},"id":{"eki":["158780638X"],"doi":["10.1002/ijc.31795"]},"relHost":[{"titleTranslated":[{"translated":"Journal international du cancer"}],"disp":"A universal anti-cancer vaccine Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalInternational journal of cancer","corporate":[{"role":"isb","display":"International Union against Cancer"}],"language":["eng"],"part":{"issue":"4","volume":"144","extent":"13","text":"144(2019), 4, Seite 909-921","pages":"909-921","year":"2019"},"titleAlt":[{"title":"Predictive oncology"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"origin":[{"dateIssuedKey":"1966","publisher":"Wiley-Liss","publisherPlace":"Bognor Regis","dateIssuedDisp":"1966-"}],"title":[{"title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"269532781","pubHistory":["1.1966 -"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1097-0215"],"eki":["269532781"],"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"]}}],"person":[{"role":"aut","given":"Adi","display":"Sharbi Yunger, Adi","family":"Sharbi Yunger"},{"role":"aut","given":"Mareike","family":"Grees","display":"Grees, Mareike"},{"role":"aut","given":"Stefan B.","family":"Eichmüller","display":"Eichmüller, Stefan B."},{"family":"Utikal","display":"Utikal, Jochen","role":"aut","given":"Jochen"},{"role":"aut","given":"Viktor","family":"Umansky","display":"Umansky, Viktor"},{"display":"Eisenbach, Lea","family":"Eisenbach","given":"Lea","role":"aut"}],"language":["eng"],"title":[{"title_sort":"universal anti-cancer vaccine","subtitle":"Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival","title":"A universal anti-cancer vaccine"}],"note":["Online 14 Aug 2018","Gesehen am 19.02.2019"],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a SHARBIYUNGUNIVERSALA2019 | ||